Margarita Rio-Del

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Journal: Cephalalgia : an international journal of headache

Published: June 19, 2026

Caloric-vHIT Dissociation in Vestibular Migraine: An Observational, Retrospective Case Series Study.

Caloric-vHIT Dissociation in Vestibular Migraine: An Observational, Retrospective Case Series Study.

Journal: Journal of clinical medicine

Published: June 08, 2026

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Journal: Cephalalgia : an international journal of headache

Published: June 05, 2026

Correction: What's a migraine day? Towards a consensus definition for clinical care and research - a Delphi panel-based study.

Correction: What's a migraine day? Towards a consensus definition for clinical care and research - a Delphi panel-based study.

Journal: The journal of headache and pain

Published: May 28, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

ESTELA-Study: Long-Term Effectiveness and Safety of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Real-World Clinical Practice.

ESTELA-Study: Long-Term Effectiveness and Safety of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Real-World Clinical Practice.

Journal: Brain and behavior

Published: February 13, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: January 28, 2026

Decoding the long-term safety of anti-CGRP (receptor) mAbs: a meta-analysis and systematic review.

Decoding the long-term safety of anti-CGRP (receptor) mAbs: a meta-analysis and systematic review.

Journal: The journal of headache and pain

Published: October 30, 2025

Insights into Vestibular Migraine: Diagnostic Challenges, Differential Spectrum and Therapeutic Horizons.

Insights into Vestibular Migraine: Diagnostic Challenges, Differential Spectrum and Therapeutic Horizons.

Journal: Journal of clinical medicine

Published: June 16, 2025

Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE study.

Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE study.

Journal: The journal of headache and pain

Published: April 14, 2025

Prevalence, disability, and economic impact of migraine in Spain: a nationwide population-based study.

Prevalence, disability, and economic impact of migraine in Spain: a nationwide population-based study.

Journal: The journal of headache and pain

Published: March 24, 2025

The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical Federation.

The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical Federation.

Journal: The journal of headache and pain

Published: March 20, 2025

Showing 1-12 of 38

Last Updated: 09/26/2026